The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
|Publication Year||21 Dec 2010|
|Publication status||Published - 21 Dec 2010|
|MoE publication type||H1 Granted patent|